Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

    Validate genomic variants causing human birth defects to bridge the gap from identification to functional impact using genetic data and in-silico tools.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

    NIH invites pediatric cohort samples for sequencing and other molecular analyses to uncover the genetic basis of childhood cancers and congenital anomalies, with data shared through Kids First.

    HHS-NIH11Due Jan 11, 2027

    Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

    NIH funds centers to systematically test how genomic variants affect genome function and phenotypes, develop reproducible data pipelines, and collaborate in a consortium; clinical trials are not allowed.

    HHS-NIH11Due Dec 14, 2026$10,000,000

    Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

    Supports centers generating high-quality genomic data from human specimens representing childhood cancers and congenital anomalies for the Gabriella Miller Kids First Pediatric Research Program.

    HHS-NIH11Due Jan 8, 2027$10,500,000

    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

    Develop new screening methods and treatments for newborns with potentially fatal or disabling disorders identified through newborn screening, focusing on high priority genetic conditions with potential for future screening.

    HHS-NIH11Due Feb 16, 2027$275,000

    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

    Funding for innovative methods to screen and treat potentially fatal disorders in newborns, including genetic conditions needing screening advancements.

    HHS-NIH11Due Feb 5, 2027